Navigation Links
Echo Therapeutics to Present at the New York Society of Security Analysts' 13th Annual Biotech and Specialty Pharmaceuticals Conference
Date:11/24/2009

FRANKLIN, Mass., Nov. 24 /PRNewswire-FirstCall/ -- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a company developing its needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and its Prelude(TM) SkinPrep System for transdermal drug delivery, announced today that Patrick T. Mooney, M.D., Chairman and Chief Executive Officer, will present at the 13th Annual Biotech and Specialty Pharmaceuticals Conference, sponsored by the New York Society of Securities Analysts, at 2:05 on December 1, 2009. The conference is being held at the offices of the New York Society of Security Analysts, 1177 Avenue of the Americas, New York, NY.

For further information about this conference, please contact Derly Vargas at 646-871-3405 or dvargas@nyssa.org.

About Echo Therapeutics

Echo Therapeutics is focused on medical devices and specialty pharmaceuticals. Echo is developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system for patients with diabetes and for use in hospital critical care units. Echo is also developing its needle-free Prelude SkinPrep System for transdermal drug delivery of a wide range of novel topical reformulations of widely-used, FDA-approved products.

Cautionary Statement Regarding Forward Looking Statements

The statements in this press release that are not historical facts may constitute forward-looking statements that are based on current expectations and are subject to risks and uncertainties that could cause actual future results to differ materially from those expressed or implied by such statements. Those risks and uncertainties include, but are not limited to, risks related to regulatory approvals and the success of Echo's ongoing studies, including the efficacy of Echo's Symphony tCGM System an
'/>"/>

Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
2. Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis
3. Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal
4. Echo Therapeutics Announces Positive Results of a Clinical Study Testing Symphony(TM) tCGM System in Patients with Type 1 and Type 2 Diabetes
5. Mersana Therapeutics Provides Clinical Update from Ongoing Phase 1 Study of XMT-1001 in Patients with Advanced Solid Tumors
6. Oxygen Biotherapeutics, Inc. Begins Shipping Cosmetic Product to Customers
7. Paloma Pharmaceuticals Presents at the AACR-NCI-EORTC International Conference Molecular Targets and Cancer Therapeutics
8. Senesco Presents Pre-Clinical Stability and Biological Activity Data on SNS-01 at the 2009 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
9. Orexigen(R) Therapeutics to Speak at Lazard Capital Markets Healthcare Conference
10. Tobira Therapeutics Announces Presentation of TBR-652 Data at European AIDS Conference
11. Reportlinker Adds Pain Therapeutics 2005: Market Dynamics and Outlook
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... ALTO, Calif. , Sept. 30, 2014 /PRNewswire/ ... investment group focused on supporting promising emerging biotech, ... has been named the Top Angel Investment Group ... Insights as the best performer out of 370 ... included: historical performance, network strength (connections), selection aptitude ...
(Date:9/30/2014)... 2014 Organovo Holdings, Inc. (NYSE MKT: ... delivering breakthrough 3D bioprinting technology, announced today that ... a finalist in the Diagnostics & Research Tools ... Awards, sponsored by CONNECT. CONNECT, a regional program that ... sciences products in San Diego County ...
(Date:9/30/2014)... Inc. ( www.synapsebiomedical.com ) announced today it has ... its NeuRx DPS® System for ALS patients.  The ... requirement was implanted over a month and a ... is the only medical device approved by the ... device that obtained approval at the end of ...
Breaking Medicine Technology:Life Science Angels Ranked the Top Angel Investment Group in the U.S. 2Life Science Angels Ranked the Top Angel Investment Group in the U.S. 3Organovo Inc. Selected As A Finalist In 27th Annual CONNECT Most Innovative New Product Awards 2Organovo Inc. Selected As A Finalist In 27th Annual CONNECT Most Innovative New Product Awards 3Synapse Biomedical Announces the Early Completion of Enrollment in the FDA Post Approval Study for ALS Patients 2Synapse Biomedical Announces the Early Completion of Enrollment in the FDA Post Approval Study for ALS Patients 3
... CHICAGO, May 16, 2012 /PRNewswire-iReach/ -- Chronic ... most common causes of persistent, debilitating back pain. Chicago ... compromised his livelihood and soured his outlook on life. ... many doctors, he finally found relief with non-surgical treatment ...
... The sleep apnea diagnostics devices market has witnessed ... caused by improved awareness. The market is currently in ... largely dependent on the degree of awareness of sleep ... Frost & Sullivan ( http://www.patientmonitoring.frost.com ), Strategic Analysis ...
Cached Medicine Technology:The Illinois Back Institute Helps Patient Beat Debilitating Back Pain 2Heightened Awareness, Coupled with Expanding Patient Pool, Stimulates Sleep Apnea Diagnostics and Sleep Services Market, Says Frost & Sullivan 2Heightened Awareness, Coupled with Expanding Patient Pool, Stimulates Sleep Apnea Diagnostics and Sleep Services Market, Says Frost & Sullivan 3
(Date:9/30/2014)... Jose, California (PRWEB) September 30, 2014 ... are organic compounds, which are mixed with animal feed ... weight gain, and improve gut health and digestion. Amidst ... milk, eggs and meat across the globe, the need ... and aquaculture sectors is on the rise, thereby driving ...
(Date:9/30/2014)... Eastern Finland shows that dietary polyunsaturated fatty acids may ... of polyunsaturated fatty acids include fish, vegetable oils, and ... & Vascular Biology , an esteemed journal of the ... an association between the consumption of saturated fats and ... mere reduction of saturated fats from the diet does ...
(Date:9/30/2014)... Amy Norton ... News) -- Long-acting contraceptive devices should be the first ... from the American Academy of Pediatrics state. Although ... pills, two other forms of contraception -- intrauterine devices ... according to the academy. And they should be ...
(Date:9/30/2014)... Visit Pam and Steve’s quiet home in ... find a loving couple facing the most monumental challenge ... , Steve was diagnosed with ALS – more commonly ... before the couple’s second wedding anniversary. Pam is ... “Care, Support & ALS,” that’s part of ...
(Date:9/30/2014)... Neuromuscular and central nervous system ... States and worldwide. It is estimated that 50,000-60,000 ... year, adding to the more than one million ... people in the US are affected by Multiple ... statistics the 2.4 percent of the US population ...
Breaking Medicine News(10 mins):Health News:Rising Consumption of Meat and Meat Products to Fuel Growth in the Global Feed Acidifiers Market, According to New Report by Global Industry Analysts, Inc. 2Health News:Rising Consumption of Meat and Meat Products to Fuel Growth in the Global Feed Acidifiers Market, According to New Report by Global Industry Analysts, Inc. 3Health News:Dietary polyunsaturated fatty acids linked to smaller risk of coronary heart disease 2Health News:Pediatricians Endorse IUDs, Implants for Teen Birth Control 2Health News:Pediatricians Endorse IUDs, Implants for Teen Birth Control 3Health News:Hospice Provides Care and Support to Patients and Family Caregivers with ALS 2Health News:North American Seminars Introduces a New OT PT CME Course, Evidence Based Rehab Techniques for Parkinsons, Multiple Sclerosis and Peripheral Neuropathy 2Health News:North American Seminars Introduces a New OT PT CME Course, Evidence Based Rehab Techniques for Parkinsons, Multiple Sclerosis and Peripheral Neuropathy 3
... Research, Inc.,(Scimitar) issues a review of StatSure Diagnostic ... for Investors Seeking,to Participate In a Proprietary Point-of-Care ... website: http://www.scimitarequity.com . ABOUT STATSURE ... development,manufacture and marketing of rapid immunoassay tests for ...
... Valve Repair Product Portfolio, MINNEAPOLIS, Oct. ... ), manufacturer and marketer of state-of-the-art cardiac,surgery ... and Drug,Administration (FDA) clearance for the ATS ... the next in a series of,mitral valve ...
... to Provide Funding and Support for "Patient Navigator,Program" ... Everett, Washington, EVERETT, Wash., Oct. 25 ... new Patient Navigator Program at,the Providence Regional Cancer ... one part of a strategic nationwide effort to,significantly ...
... for interviews, OAKLAND, Calif., Oct. 25 ... volunteer,registered nurses through its Registered Nurse Response Network ... the spreading disaster,created by wildfires in the region. ... to shelters in San Diego,County in response to ...
... House Republican Whip,Roy Blunt (Mo.) issued the following ... children,s health program created by,Republicans to expand taxpayer-funded care ... in some cases, not even in this country legally:, ... take our concerns to heart and,come back with an ...
... 25 Darwin,Professional Underwriters, Inc. (Darwin) (NYSE: ... its third quarter 2007 financial results following the,close ... conference call to,discuss the company,s third quarter 2007 ... 2007 at 8:00 a.m. Eastern Time. (Logo: ...
Cached Medicine News:Health News:StatSure Diagnostic Systems, Inc. (OTC Bulletin Board: SSUR) Review Issued By Scimitar Equity Research, Inc. 2Health News:ATS Medical Receives FDA Clearance for ATS Simulus Semi-Rigid Annuloplasty Ring 2Health News:ATS Medical Receives FDA Clearance for ATS Simulus Semi-Rigid Annuloplasty Ring 3Health News:Everett-Area Cancer Patients Can More Easily Navigate Health Care System Thanks to the American Cancer Society and AstraZeneca 2Health News:Everett-Area Cancer Patients Can More Easily Navigate Health Care System Thanks to the American Cancer Society and AstraZeneca 3Health News:Everett-Area Cancer Patients Can More Easily Navigate Health Care System Thanks to the American Cancer Society and AstraZeneca 4Health News:Everett-Area Cancer Patients Can More Easily Navigate Health Care System Thanks to the American Cancer Society and AstraZeneca 5Health News:CNA/NNOC Nurse Volunteers Deployed to Southern California Firestorm 2Health News:Darwin to Announce Third Quarter 2007 Financial Results 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: